-
公开(公告)号:US11744944B2
公开(公告)日:2023-09-05
申请号:US16898529
申请日:2020-06-11
Applicant: Insulet Corporation
Inventor: Jason O'Connor , Daniel Allis , David Nazzaro , John R. Bussiere , John D'Arco
CPC classification number: A61M5/1723 , A61M5/14248 , G16H20/17 , G16H40/63 , A61M2205/27 , A61M2205/3569 , A61M2205/3584 , A61M2205/581 , A61M2205/582 , A61M2205/583 , A61M2205/8206 , A61M2230/201
Abstract: Systems and methods for automatically delivering medication to a user. A sensor coupled to a user can collect information regarding the user. A controller can use the collected information to determine an amount of medication to provide the user. The controller can instruct a drug delivery device to dispense the medication to the user. The drug delivery device can be a wearable insulin pump that is directly coupled to the user. The controller can be part of or implemented in a cellphone. A user can be required to provide a confirmation input to allow a determined amount of insulin to be provided to the user based on detected glucose levels of the user. The sensor, controller, and drug delivery device can communicate wirelessly.
-
公开(公告)号:US11565039B2
公开(公告)日:2023-01-31
申请号:US16599729
申请日:2019-10-11
Applicant: INSULET CORPORATION
Inventor: Jason O'Connor , Joon Bok Lee , Ian McLaughlin , John D'Arco
Abstract: A drug delivery device may include an Inertial Measurement Unit (IMU) is provided. The IMU may include an accelerometer, a magnetometer, or a gyroscope. Motion parameters may be detected when the drug delivery device is shipped, being prepared for activation for use, or during use. The IMU may provide data indicative of a rapid deceleration, such as when a package containing the drug delivery device is dropped, or some other physical event experienced by the drug delivery device. The drug delivery device may also include internal or external pressure sensors or a blood glucose sensor that may coordinate with the IMU to provide additional feedback regarding the status of the device or user. A controller of the drug delivery device may generate a response depending on the particular parameters being monitored or may change device operational parameters as a result of detected system events.
-
公开(公告)号:US11241532B2
公开(公告)日:2022-02-08
申请号:US16116071
申请日:2018-08-29
Applicant: Insulet Corporation
Inventor: David Nazzaro , John D'Arco , Jason O'Connor , Ian McLaughlin
Abstract: A drug delivery system having a drug delivery device and an associated sensor is provided. The sensor can be associated with a sensing site on user. The drug delivery device can be positioned over the sensor in any rotational position and can be associated with an infusion site on the user. The close positioning of the sensor and the drug delivery device allows data from the sensor to be relayed to the drug delivery device and then on to a remote control device. Further, the drug delivery device can be replaced at the end of its duration of use, which is shorter than the duration of use of the sensor, without disturbing the sensor. Subsequent drug delivery devices can then be used with the sensor while allowing each corresponding infusion site to be changed, thereby providing more efficient operation of the drug delivery system.
-
公开(公告)号:US11090434B2
公开(公告)日:2021-08-17
申请号:US17079393
申请日:2020-10-23
Applicant: Insulet Corporation
Inventor: Jason O'Connor , Daniel Allis , David Nazzaro , John R. Bussiere , John D'Arco
Abstract: Systems and methods for automatically delivering medication to a user. An automated drug delivery system may include a sensor and a wearable automated drug delivery device. The wearable automated drug delivery device may be configured to couple to the skin of a user and may include a controller and a pump. The pump may be configured to output the medication. The controller may be within the wearable automated drug delivery device. The sensor may be coupled to the user and may be configured to collect information regarding the user. The controller of the wearable automated drug delivery device may use the collected information to locally determine an amount of medication to be output from the wearable automated drug delivery device and cause delivery of the amount of medication.
-
公开(公告)号:US20250135114A1
公开(公告)日:2025-05-01
申请号:US18924403
申请日:2024-10-23
Applicant: Insulet Corporation
Inventor: John R. Bussiere , James Causey , John D'Arco
Abstract: Systems for measuring analyte in a user-body of a patient, delivering medicaments to the user-body, and deployment of components thereof are disclosed. The systems include combinations of an analyte sensor, an automated medicament delivery system, a cradle configured to hold the analyte sensor and the automated medicament delivery system on the user-body, and a deployment inserter configured to deploy one or more of the analyte sensor, the automated medicament delivery system, and the cradle onto the user-body.
-
公开(公告)号:US10716896B2
公开(公告)日:2020-07-21
申请号:US15359187
申请日:2016-11-22
Applicant: INSULET CORPORATION
Inventor: Jason O'Connor , Daniel Allis , David Nazzaro , John R. Bussiere , John D'Arco
Abstract: Systems and methods for automatically delivering medication to a user. A sensor coupled to a user can collect information regarding the user. A controller can use the collected information to determine an amount of medication to provide the user. The controller can instruct a drug delivery device to dispense the medication to the user. The drug delivery device can be a wearable insulin pump that is directly coupled to the user. The controller can be part of or implemented in a cellphone. A user can be required to provide a confirmation input to allow a determined amount of insulin to be provided to the user based on detected glucose levels of the user. The sensor, controller, and drug delivery device can communicate wirelessly.
-
-
-
-
-